Hello, Visitor!

You know it's sad when your domain is nowhere to be found on Google and Yahoo, while Wordpress sites are occupying first pages for a keyword that 100% matches your domainâ?¦ It's the pain domainers have learned to live with, because when you have 100s or even 1000s of internet properties under management it's practically impossible to develop them allâ?¦ right?

Wrong! VisitorDay's unique patent-pending features allow domainers to fully develop EVERY domain in their portfolio within an HOUR. After that, all you have to do is to watch the analytics and fine-tune certain domains that need adjustment.

user
passwsord

Powered By www.VisitorDAY.com
Terms & Conditions Privacy Policy

Tags

BioTech

Domain Info:



For Sale

GENOMICDRUGS.COM



Site Monthly visits: 334
Advertise for $0.04/Day


Trending on Social Networks
VisitorDay Search
Sorry, no results found in
knowledge-sharing database for these terms.

Business Listing

"Advertise your site here by describing your Expertise and how you can benefit Visitor Day Community."

Click Here

Trending on the Internet
Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, is pleased to announce it has renewed the service agreement with Pure Advertising and ...
EXTON, Pa., Jan 13, 2012 (BUSINESS WIRE) -- Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has licensed its HibTITER(R) vaccine to Mitsubishi Tanabe Pharma Corporation (head office:Osaka)(head office ...
LONDON, Jan 17, 2012 (BUSINESS WIRE) -- Edison Investment Research, a UK-based independent equity research firm, announces the initiation of research coverage on Transgene (nyse euronext paris:TNG), a French immunotherapy drug discovery and ...
It's been a bit of a wild week for small cap stocks Novavax, Inc. (NVAX), RXi Pharmaceuticals Corporation (RXII), and Apricus Biosciences, Inc. (APRI). We've seen lots of twists and turns for these biotech names, prompted by plenty of attention and news ...
  • Cheap Hotels
    Find chippest hotels in a history of finding chip hotels
    www.ChipestShithall.edu
  • Cheap Hotels
    Find chippest hotels in a history of finding chip hotels
    www.ChipestShithall.edu
Scoop: Clovis Oncology CEO Patrick Mahaffy, a Pharmion co-founder, raised $145 million in venture capital with no drugs in the pipeline, but a slate of experienced biotech executives dedicated to identifying a handful of promising oncology drug ...
The federal criminal trial against Stryker Biotech and three former sales managers began Jan. 12 in Boston, Bloomberg Businessweek reported. U.S. Assistant Attorney Susan Winkler told the jury that the Hopkinton, Mass.-based unit put patients at ...
  • Cheap Hotels
    Find chippest hotels in a history of finding chip hotels
    www.ChipestShithall.edu
  • Cheap Hotels
    Find chippest hotels in a history of finding chip hotels
    www.ChipestShithall.edu
NEW YORK, Jan. 16, 2012 /PRNewswire/ --  Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0760623/Biotech-Company-Outlook-to-2016.html#utm_source=prnewswire&utm_medium=pr ...
SAN DIEGO--(EON: Enhanced Online News)--XIFIN Inc., the company revolutionizing revenue cycle management for diagnostic service providers, announced today that American International Biotechnology Services, LLC (AI BioTech) a leading clinical research ...
Anyone hoping to see a strong year for biotech IPOs last year was sorely disappointed. A paltry 10 U.S. companies went public last year, down from 13 in 2010. The biggest IPO of 2011 was Clovis Oncology, which raised $130 million to finance a ...
It's certainly not Breaking News that M&A deals are an important source of liquidity in biotech VC today.  But last year did mark an important milestone for biotech over the past few years: in 2011, the capital returned to investors from ...